Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Fire on the Range: Rangeland Fire Protection Associations as Disaster Response Organizations.

Davis EJ, Abrams J, Wollstein K.

Disasters. 2019 Jul 11. doi: 10.1111/disa.12389. [Epub ahead of print]

PMID:
31294854
2.

Empiric Therapy with BRAF and MEK Inhibitors in Metastatic Melanoma.

Cann CG, Tillman BF, Davis EJ, Johnson DB.

Oncologist. 2019 Jun 18. pii: theoncologist.2019-0332. doi: 10.1634/theoncologist.2019-0332. [Epub ahead of print]

PMID:
31213499
3.

Photon-Mediated Spin-Exchange Dynamics of Spin-1 Atoms.

Davis EJ, Bentsen G, Homeier L, Li T, Schleier-Smith MH.

Phys Rev Lett. 2019 Jan 11;122(1):010405. doi: 10.1103/PhysRevLett.122.010405.

PMID:
31012698
4.

Association of Anti-Programmed Cell Death 1 Cutaneous Toxic Effects With Outcomes in Patients With Advanced Melanoma.

Quach HT, Dewan AK, Davis EJ, Ancell KK, Fan R, Ye F, Johnson DB.

JAMA Oncol. 2019 Apr 18. doi: 10.1001/jamaoncol.2019.0046. [Epub ahead of print] No abstract available.

PMID:
30998826
5.

Clinical Correlates of Response to Anti-PD-1-based Therapy in Patients With Metastatic Melanoma.

Davis EJ, Perez MC, Ayoubi N, Zhao S, Ye F, Wang DY, Sosman JA, Al-Rohil RN, Eroglu Z, Johnson DB.

J Immunother. 2019 Jul/Aug;42(6):221-227. doi: 10.1097/CJI.0000000000000258.

PMID:
30882548
6.

Hematologic Complications of Immune Checkpoint Inhibitors.

Davis EJ, Salem JE, Young A, Green JR, Ferrell PB, Ancell KK, Lebrun-Vignes B, Moslehi JJ, Johnson DB.

Oncologist. 2019 May;24(5):584-588. doi: 10.1634/theoncologist.2018-0574. Epub 2019 Feb 28.

7.

Targeting tissue factor in advanced solid tumours.

Davis EJ, Johnson DB.

Lancet Oncol. 2019 Mar;20(3):318-319. doi: 10.1016/S1470-2045(18)30912-4. Epub 2019 Feb 8. No abstract available.

PMID:
30745091
8.

Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model.

Chugh R, Griffith KA, Davis EJ, Thomas DG, Zavala JD, Metko G, Brockstein B, Undevia SD, Stadler WM, Schuetze SM.

Ann Oncol. 2019 Feb 5. doi: 10.1093/annonc/mdy557. [Epub ahead of print] No abstract available.

PMID:
30726873
9.

Contributions of Mainstream Sexual Media Exposure to Sexual Attitudes, Perceived Peer Norms, and Sexual Behavior: A Meta-Analysis.

Coyne SM, Ward LM, Kroff SL, Davis EJ, Holmgren HG, Jensen AC, Erickson SE, Essig LW.

J Adolesc Health. 2019 Apr;64(4):430-436. doi: 10.1016/j.jadohealth.2018.11.016. Epub 2019 Jan 26. Review.

PMID:
30691937
10.

Ovarian Cycle Stages Modulate Alzheimer-Related Cognitive and Brain Network Alterations in Female Mice.

Broestl L, Worden K, Moreno AJ, Davis EJ, Wang D, Garay B, Singh T, Verret L, Palop JJ, Dubal DB.

eNeuro. 2018 Dec 14;5(6). pii: ENEURO.0132-17.2018. doi: 10.1523/ENEURO.0132-17.2018. eCollection 2018 Nov-Dec.

11.

Female XX sex chromosomes increase survival and extend lifespan in aging mice.

Davis EJ, Lobach I, Dubal DB.

Aging Cell. 2019 Feb;18(1):e12871. doi: 10.1111/acel.12871. Epub 2018 Dec 17.

12.

Painting Nonclassical States of Spin or Motion with Shaped Single Photons.

Davis EJ, Wang Z, Safavi-Naeini AH, Schleier-Smith MH.

Phys Rev Lett. 2018 Sep 21;121(12):123602. doi: 10.1103/PhysRevLett.121.123602.

PMID:
30296158
13.

Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.

Wang DY, Salem JE, Cohen JV, Chandra S, Menzer C, Ye F, Zhao S, Das S, Beckermann KE, Ha L, Rathmell WK, Ancell KK, Balko JM, Bowman C, Davis EJ, Chism DD, Horn L, Long GV, Carlino MS, Lebrun-Vignes B, Eroglu Z, Hassel JC, Menzies AM, Sosman JA, Sullivan RJ, Moslehi JJ, Johnson DB.

JAMA Oncol. 2018 Dec 1;4(12):1721-1728. doi: 10.1001/jamaoncol.2018.3923. Erratum in: JAMA Oncol. 2018 Dec 1;4(12):1792.

PMID:
30242316
14.

Poor treatment outcomes with palliative gemcitabine and docetaxel chemotherapy in advanced and metastatic synovial sarcoma.

Pender A, Davis EJ, Chauhan D, Messiou C, Al-Muderis O, Thway K, Fisher C, Zaidi S, Miah A, Judson I, van der Graaf W, Keedy VL, Benson C, Jones RL.

Med Oncol. 2018 Aug 20;35(10):131. doi: 10.1007/s12032-018-1193-5.

15.

Photothermal Heating and Cooling of Nanostructures.

Crane MJ, Zhou X, Davis EJ, Pauzauskie PJ.

Chem Asian J. 2018 Sep 17;13(18):2575-2586. doi: 10.1002/asia.201800251. Epub 2018 Aug 17. Review.

PMID:
29890034
16.

Melanoma: What do all the mutations mean?

Davis EJ, Johnson DB, Sosman JA, Chandra S.

Cancer. 2018 Sep 1;124(17):3490-3499. doi: 10.1002/cncr.31345. Epub 2018 Apr 17. Review.

PMID:
29663336
17.

Impact of a Statewide Oral Oncolytic Initiative on Five Participating Practices.

Mackler E, Scappaticci GB, Salgado TM, Petersen L, Davis EJ, Peltier E, Griggs JJ, Sabo RT, Farris KB.

J Oncol Pract. 2018 May;14(5):e304-e309. doi: 10.1200/JOP.18.00058. Epub 2018 Apr 11.

PMID:
29641272
18.

Toxicities Associated With PD-1/PD-L1 Blockade.

Wang DY, Johnson DB, Davis EJ.

Cancer J. 2018 Jan/Feb;24(1):36-40. doi: 10.1097/PPO.0000000000000296. Review.

19.

Spotlight on olaratumab in the treatment of soft-tissue sarcoma: design, development, and place in therapy.

Davis EJ, Chugh R.

Drug Des Devel Ther. 2017 Dec 13;11:3579-3587. doi: 10.2147/DDDT.S121298. eCollection 2017. Review.

20.

A meta-analysis of prosocial media on prosocial behavior, aggression, and empathic concern: A multidimensional approach.

Coyne SM, Padilla-Walker LM, Holmgren HG, Davis EJ, Collier KM, Memmott-Elison MK, Hawkins AJ.

Dev Psychol. 2018 Feb;54(2):331-347. doi: 10.1037/dev0000412. Epub 2017 Oct 30.

PMID:
29083208
21.

Enabling a genetically informed approach to cancer medicine: evaluation of the impact of comprehensive tumor sequencing.

Davis EJ, Johnson DB.

Per Med. 2017 May;14(3):189-192. doi: 10.2217/pme-2017-0014. Epub 2017 May 5.

22.

Comparison of USDA Forest Service and Stakeholder Motivations and Experiences in Collaborative Federal Forest Governance in the Western United States.

Davis EJ, White EM, Cerveny LK, Seesholtz D, Nuss ML, Ulrich DR.

Environ Manage. 2017 Nov;60(5):908-921. doi: 10.1007/s00267-017-0913-5. Epub 2017 Aug 16.

PMID:
28815317
23.

The Effect of Media on Body Image in Pregnant and Postpartum Women.

Coyne SM, Liechty T, Collier KM, Sharp AD, Davis EJ, Kroff SL.

Health Commun. 2018 Jul;33(7):793-799. doi: 10.1080/10410236.2017.1314853. Epub 2017 May 8.

PMID:
28481162
24.

Next generation sequencing of extraskeletal myxoid chondrosarcoma.

Davis EJ, Wu YM, Robinson D, Schuetze SM, Baker LH, Athanikar J, Cao X, Kunju LP, Chinnaiyan AM, Chugh R.

Oncotarget. 2017 Mar 28;8(13):21770-21777. doi: 10.18632/oncotarget.15568.

25.

Identifying socio-demographic and clinical characteristics associated with medication beliefs about aromatase inhibitors among postmenopausal women with breast cancer.

Salgado TM, Davis EJ, Farris KB, Fawaz S, Batra P, Henry NL.

Breast Cancer Res Treat. 2017 Jun;163(2):311-319. doi: 10.1007/s10549-017-4177-9. Epub 2017 Mar 1.

PMID:
28251384
26.

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy.

Davis EJ, Zhao L, Lucas DR, Schuetze SM, Baker LH, Zalupski MM, Thomas D, Chugh R.

BMC Cancer. 2016 Aug 20;16:663. doi: 10.1186/s12885-016-2694-2.

27.

Sleep deprivation impairs memory by attenuating mTORC1-dependent protein synthesis.

Tudor JC, Davis EJ, Peixoto L, Wimmer ME, van Tilborg E, Park AJ, Poplawski SG, Chung CW, Havekes R, Huang J, Gatti E, Pierre P, Abel T.

Sci Signal. 2016 Apr 26;9(425):ra41. doi: 10.1126/scisignal.aad4949.

28.

A Phase II Study of Biweekly Cisplatin, Fixed-Dose-Rate Gemcitabine and Infusional 5-Fluorouracil in Patients With Metastatic Pancreatic and Biliary Cancers.

Davis EJ, Griffith KA, Kim EJ, Ruch JM, McDonnell KJ, Zalupski MM.

Am J Clin Oncol. 2018 Feb;41(2):128-132. doi: 10.1097/COC.0000000000000240.

29.

Chiral dopants and the twist-bend nematic phase--induction of novel mesomorphic behaviour in an apolar bimesogen.

Archbold CT, Davis EJ, Mandle RJ, Cowling SJ, Goodby JW.

Soft Matter. 2015 Oct 14;11(38):7547-57. doi: 10.1039/c5sm01935d.

PMID:
26279398
30.

A randomised, open-label, phase II study of neo/adjuvant doxorubicin and ifosfamide versus gemcitabine and docetaxel in patients with localised, high-risk, soft tissue sarcoma.

Davis EJ, Chugh R, Zhao L, Lucas DR, Biermann JS, Zalupski MM, Feng M, Wong SL, Jacobson J, Zyczynski L, Reinke D, Metko G, Baker LH, Schuetze SM.

Eur J Cancer. 2015 Sep;51(13):1794-802. doi: 10.1016/j.ejca.2015.05.010. Epub 2015 Jun 9.

PMID:
26066736
31.

Apolar bimesogens and the incidence of the twist-bend nematic phase.

Mandle RJ, Davis EJ, Archbold CT, Voll CC, Andrews JL, Cowling SJ, Goodby JW.

Chemistry. 2015 May 26;21(22):8158-67. doi: 10.1002/chem.201500423. Epub 2015 Apr 20.

PMID:
25900846
32.

Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model.

Chugh R, Griffith KA, Davis EJ, Thomas DG, Zavala JD, Metko G, Brockstein B, Undevia SD, Stadler WM, Schuetze SM.

Ann Oncol. 2015 Jul;26(7):1459-64. doi: 10.1093/annonc/mdv171. Epub 2015 Apr 9.

33.

Self-organizing behaviour of glycosteroidal bolaphiles: insights into lipidic microsegregation.

Xu R, Ali-Rachedi F, Xavier NM, Chambert S, Ferkous F, Queneau Y, Cowling SJ, Davis EJ, Goodby JW.

Org Biomol Chem. 2015 Jan 21;13(3):783-92. doi: 10.1039/c4ob02191f.

PMID:
25388281
34.

Risk of second primary tumors in men diagnosed with prostate cancer: a population-based cohort study.

Davis EJ, Beebe-Dimmer JL, Yee CL, Cooney KA.

Cancer. 2014 Sep 1;120(17):2735-41. doi: 10.1002/cncr.28769. Epub 2014 May 19.

35.

Synthesis and characterisation of an unsymmetrical, ether-linked, fluorinated bimesogen exhibiting a new polymorphism containing the N(TB) or 'twist-bend' phase.

Mandle RJ, Davis EJ, Lobato SA, Vol CC, Cowling SJ, Goodby JW.

Phys Chem Chem Phys. 2014 Apr 21;16(15):6907-15. doi: 10.1039/c4cp00172a. Epub 2014 Feb 18.

PMID:
24535404
36.

Nanowire heating by optical electromagnetic irradiation.

Roder PB, Pauzauskie PJ, Davis EJ.

Langmuir. 2012 Nov 20;28(46):16177-85. doi: 10.1021/la303250e. Epub 2012 Nov 7.

PMID:
23061375
37.

DVC1 (C1orf124) recruits the p97 protein segregase to sites of DNA damage.

Davis EJ, Lachaud C, Appleton P, Macartney TJ, Näthke I, Rouse J.

Nat Struct Mol Biol. 2012 Nov;19(11):1093-100. doi: 10.1038/nsmb.2394. Epub 2012 Oct 7.

PMID:
23042607
38.

Clinical spectrum of tuberculous optic neuropathy.

Davis EJ, Rathinam SR, Okada AA, Tow SL, Petrushkin H, Graham EM, Chee SP, Guex-Crosier Y, Jakob E, Tugal-Tutkun I, Cunningham ET Jr, Leavitt JA, Mansour AM, Winthrop KL, Hills WL, Smith JR.

J Ophthalmic Inflamm Infect. 2012 Dec;2(4):183-9. doi: 10.1007/s12348-012-0079-5. Epub 2012 May 22.

39.

Improved ion mobility resolving power with increased buffer gas pressure.

Davis EJ, Grows KF, Siems WF, Hill HH Jr.

Anal Chem. 2012 Jun 5;84(11):4858-65. doi: 10.1021/ac300452j. Epub 2012 May 23.

PMID:
22591048
40.

Radiative ion-ion neutralization: a new gas-phase atmospheric pressure ion transduction mechanism.

Davis EJ, Siems WF, Hill HH Jr.

Anal Chem. 2012 Jun 5;84(11):4760-7. doi: 10.1021/ac3002534. Epub 2012 May 11.

PMID:
22548633
41.

Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States.

Krishnarajah G, Davis EJ, Fan Y, Standaert BA, Buikema AR.

Vaccine. 2012 May 21;30(24):3717-22. doi: 10.1016/j.vaccine.2011.12.077. Epub 2011 Dec 31.

PMID:
22214886
42.

Healthcare costs and nonadherence among chronic opioid users.

Leider HL, Dhaliwal J, Davis EJ, Kulakodlu M, Buikema AR.

Am J Manag Care. 2011 Jan;17(1):32-40.

43.

Voltage sweep ion mobility spectrometry.

Davis EJ, Williams MD, Siems WF, Hill HH Jr.

Anal Chem. 2011 Feb 15;83(4):1260-7. doi: 10.1021/ac1021002. Epub 2011 Jan 21.

PMID:
21254780
44.

A review of treatment response in type 2 diabetes: assessing the role of patient heterogeneity.

Cantrell RA, Alatorre CI, Davis EJ, Zarotsky V, Le Nestour E, Carter GC, Goetz I, Paczkowski R, Sierra-Johnson J.

Diabetes Obes Metab. 2010 Oct;12(10):845-57. doi: 10.1111/j.1463-1326.2010.01248.x. Review.

PMID:
20920036
45.

Glaucoma medication persistence with a fixed combination versus multiple bottles.

Higginbotham EJ, Hansen J, Davis EJ, Walt JG, Guckian A.

Curr Med Res Opin. 2009 Oct;25(10):2543-7. doi: 10.1185/03007990903260129.

PMID:
19731993
46.

Cost of illness of glaucoma: a critical and systematic review.

Fiscella RG, Lee J, Davis EJ, Walt J.

Pharmacoeconomics. 2009;27(3):189-98. doi: 10.2165/00019053-200927030-00002. Review.

PMID:
19354339
47.

High-pressure ion mobility spectrometry.

Davis EJ, Dwivedi P, Tam M, Siems WF, Hill HH.

Anal Chem. 2009 May 1;81(9):3270-5. doi: 10.1021/ac802431q.

48.

Searching for new cell wall protein genes in Arabidopsis.

Davis EJ, Chen D, Dewald DB, Shope J, MacAdam J, Wu Y.

Plant Physiol Biochem. 2009 Feb;47(2):81-5. doi: 10.1016/j.plaphy.2008.10.003. Epub 2008 Oct 18.

PMID:
19027309
49.

Elevated plasma levels of alpha-1-anti-chymotrypsin in age-related cognitive decline and Alzheimer's disease: a potential therapeutic target.

Porcellini E, Davis EJ, Chiappelli M, Ianni E, Di Stefano G, Forti P, Ravaglia G, Licastro F.

Curr Pharm Des. 2008;14(26):2659-64.

PMID:
18991685
50.

Interpretation of uptake coefficient data obtained with flow tubes.

Davis EJ.

J Phys Chem A. 2008 Mar 6;112(9):1922-32. doi: 10.1021/jp074939j. Epub 2008 Feb 12.

PMID:
18266341

Supplemental Content

Loading ...
Support Center